BioPharma Drug Approval
Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
December 04, 2024 | News
Everest Medicines , a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeut...
December 03, 2024 | News
The National Healthcare Security Administration of China has unveiled the 2024 National Reimbursement Drug List (NRDL), incorporating several pioneering th...
November 29, 2024 | News
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accep...
November 25, 2024 | News
Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in their lifetime Previous studies have shown t...
November 25, 2024 | News
Eisai Co., Ltd. announced that the amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection25 mg” (mecobalamin) has ...
November 21, 2024 | News
Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing innovative therapies, announced that the U.S. Food and Drug Administ...
November 20, 2024 | News
Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy, announced that it has received appr...
November 20, 2024 | News
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
November 19, 2024 | News
IND clearance paves the way for Acepodia to enter the clinic for the first time with its autoimmune program ACE1831 is an allogeneic gamma delta T...
November 18, 2024 | News
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unm...
November 18, 2024 | News
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its novel Nectin-4 targeting ADC (R&D code: 9MW...
November 15, 2024 | News
CBL-514 is the first and only drug to receive EMA Orphan Drug Designation for Dercum's disease treatment.- CBL-514 received both FDA Orphan Drug...
November 14, 2024 | News
Alphamab Oncology (stock code: 9966.HK) announced that a clinical trial (Study ID: JSKN033-102) of JSKN033, a high-concentration subcutaneous co-formulatio...
November 13, 2024 | News
Most Read
Bio Jobs
News